Is there any relationship between cardiovascular risk markers and young women with diminished ovarian reserve?

References

• Wang TT, Ke ZH, Song Y, Chen LT, et al. Identification of a mutation in GDF9 as a novel cause of diminished ovarian reserve in young women. Hum Reprod 2013;28:2473–81
   PubMed Web of Science ®Google Scholar
• Nikolaou D, Templeton A. Early ovarian ageing: a hypothesis. Detection and clinical relevance. Hum Reprod 2003;18:1137–9
   PubMed Web of Science ®Google Scholar
• Bevc S, Sabic S, Hojs R. Atherosclerosis in hemodialysis patients – the role of microinflammation. Ren Fail 2008;30:1012–16
   PubMed Web of Science ®Google Scholar
• Ikonomidis I, Stamatelopoulos K, Lekakis J, et al. Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 2008;199:3–11
   PubMed Web of Science ®Google Scholar
• Kaptoge S, Di Angelantonio E, Lowe G, et al. Emerging risk factors collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010;375:132–40
   PubMed Web of Science ®Google Scholar
• van Wijk DF, Boekholdt SM, Wareham NJ, et al. C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study. Arterioscler Thromb Vasc Biol 2013;33:2888–94
   PubMed Web of Science ®Google Scholar
• Després JP, Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952–7
   PubMed Web of Science ®Google Scholar
• Farin HM, Abbasi F, Kim SH, et al. The relationship between insulin resistance and dyslipidaemia in cigarette smokers. Diabetes Obes Metab 2007;9:65–9
   PubMed Web of Science ®Google Scholar
• Kemp DM. Does chronic low-grade endotoxemia define susceptibility of obese humans to insulin resistance via dietary effects on gut microbiota? Adipocyte 2013;2:188–90
   PubMedGoogle Scholar
• Aroor A, McKarns S, Nistala R, et al. DPP-4 Inhibitors as therapeutic modulators of immune cell function and associated cardiovascular and renal insulin resistance in obesity and diabetes. Cardiorenal Med 2013;3:48–56
   PubMed Web of Science ®Google Scholar
• Wellons M. Cardiovascular disease and primary ovarian insufficiency. Semin Reprod Med 2011;29:328–41
   PubMed Web of Science ®Google Scholar
• Torng PL, Su TC, Sung FC, et al. Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight – the Chin-Shan Community Cardiovascular Cohort study. Atherosclerosis 2002;161:409–15
   PubMed Web of Science ®Google Scholar
• Spencer CP, Godsland H, Stevenson JC. Is there a menopausal metabolic syndrome? Gynecol Endocrinol 1977;11:341–55
   Google Scholar
• Kahapola Arachchige KM, Wardrop R, et al. Waiting for an elevated FSH – too late a marker of reduced ovarian reserve? Aust N Z J Obstet Gynaecol 2012;52:460–4
   PubMed Web of Science ®Google Scholar
• Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA Guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart association task force on practice guidelines. Circulation 2013. [Epub ahead of print]
   Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–19
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–52
   PubMed Web of Science ®Google Scholar
• Jacobsen BK, Heuch I, Kvåle G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 2003;157:923–9
   PubMed Web of Science ®Google Scholar
• de Boer EJ, den Tonkelaar I, te Velde ER, et al. OMEGA-project group. Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod 2003;18:1544–52
   PubMed Web of Science ®Google Scholar
• de Boer EJ, den Tonkelaar I, te Velde ER, et al.; OMEGA-project group. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 2002;77:978–85
   PubMed Web of Science ®Google Scholar
• Pal L, Zhang K, Zeitlian G, Santoro N. Characterizing the reproductive hormone milieu in infertile women with diminished ovarian reserve. Fertil Steril 2010;93:1074–9
   PubMed Web of Science ®Google Scholar
• Greenseid K, Jindal S, Zapantis A, et al. Declining ovarian reserve adversely influences granulosa cell viability. Fertil Steril 2009;91:2611–15
   PubMed Web of Science ®Google Scholar
• Matthews KA, Wing RR, Kuller LH, et al. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch Intern Med 1994;154:2349–55
   PubMed Web of Science ®Google Scholar
• Chu MC, Rath KM, Huie J, Taylor HS. Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk. Hum Reprod 2003;18:1570–3
   PubMed Web of Science ®Google Scholar
• Bleil ME, Gregorich SE, McConnell D, et al. Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease? Menopause 2013;20:1139–46
   PubMed Web of Science ®Google Scholar
• Gaikwad S, Garrido N, Cobo A, et al. Bed rest after embryo transfer negatively affects in vitro fertilization: a randomized controlled clinical trial. Fertil Steril 2013;100:729–35
   PubMed Web of Science ®Google Scholar
• Loftis JM, Huckans M, Morasco BJ. Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis 2010;37:519–33
   PubMed Web of Science ®Google Scholar
• Khovidhunkit W, Kim M, Memon R, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004;45:1169–96
   PubMed Web of Science ®Google Scholar
• Rizzo M, Rizvi AA, Rini GB, Berneis K. The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? Acta Diabetol 2009;46:1–11
   PubMed Web of Science ®Google Scholar
• Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest 2000;106:453–8
   PubMed Web of Science ®Google Scholar
• Hansson GK. Atherosclerosis – an immune disease: the Anitschkov Lecture 2007. Atherosclerosis 2009;202:2–10
   PubMed Web of Science ®Google Scholar
• Kelly CC, Lyall H, Petrie JR, et al. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2001;86:2453–5
   PubMed Web of Science ®Google Scholar